プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Tanja M.に依頼

United Kingdom

Research Scientist with a background in Pharmacy & Health Services Research

プロフィール概要

I am an academic researcher with experience in designing observational studies; analysing large (and small) data sets (R & SPSS); writing academic papers, reports, blogs, and essays; and reviewing manuscripts. Although my background is in quantitative health research, I have also experience with mixed-methods and qualitative research. I love writing, but I also love playing with numbers; in addition, I'm quite skilled in formatting academic/scientific output, and excel at nit-picking (AKA copy-editing). Bilingual (English/German).

専門分野

• ★ Health Data Analysis
• ★ Research Methodology
• ★ Technical & Scientific Writing
• ☆ Bioethics & Medical Ethics
• ☆ Pharmaceutical Sciences
• ☆ Pharmacy
• ☆ Public Health
• ☆ Epidemiology
• ☆ Research
• ☆ Scientific Proofreading & Editing

サービス

• Writing
• Research
• Data & AI

Writing Clinical Trial Documentation, Technical Writing, Newswriting

Research Systematic Literature Review, Secondary Data Collection

Data & AI Statistical Analysis, Data Visualization

職務経験

Research Associate

University of Strathclyde

10月 2017 - 現在

Intern

World Health Organization Regional Office for Europe

5月 2013 - 8月 2013

学歴

PhD (Strathclyde Institute of Pharmacy and Biomedical Sciences)

University of Strathclyde

2014 - 2017

MPH (Faculty of Medicine)

Lunds Universitet

2012 - 2014

BA (Business Administration)

Europäische Fernhochschule Hamburg

2008 - 2011

Pharmacist (Faculty of Life Science)

Technische Universität Carolo Wilhelmina zu Braunschweig

1997 - 2002

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Tanja Mueller, Kelly Baillie, Jiafeng Pan, Jennifer Laskey, Marion Bennie, Christine Crearie, Kimberley Kavanagh, Samantha Alvarez‐Madrazo, David Morrison, Julie Clarke, et al.(2020). Use of record linkage to evaluate treatment outcomes and trial eligibility in a real-world metastatic prostate cancer population in Scotland . Pharmacoepidemiology and Drug Safety. Wiley

Tanja Mueller, Renata Cristina Rezende Macedo do Nascimento, Brian Godman, Sean MacBride Stewart, Simon Hurding, Francisco Assis Acurcio, Augusto Afonso Guerra Junior, Juliana Alvares Teodoro, Alec Morton, Marion Bennie, et al.(2020). Real-world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population-based study . British Journal of Clinical Pharmacology. Wiley

(2020). A Bayesian hierarchical approach for multiple outcomes in routinely collected healthcare data . Statistics in Medicine.

Tanja Mueller, Marion Bennie, William Malcolm, Stuart McTaggart(2020). Improving prescribing through big data approaches{\textemdash}Ten years of the Scottish Prescribing Information System . British Journal of Clinical Pharmacology. 86. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 250--257. Wiley

(2020). Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab . Applied Health Economics and Health Policy.

Tanja Mueller, Samantha Alvarez‐Madrazo, Chris Robertson, Olivia Wu, Marion Bennie(2018). Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland . British Journal of Clinical Pharmacology. Wiley

Tanja Mueller, Samantha Alvarez-Madrazo, Chris Robertson, Marion Bennie(2017). Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: Applying a coherent framework to drug utilisation studies . Pharmacoepidemiology and Drug Safety. 26. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1378--1386. Wiley-Blackwell

Mueller, T., Östergren, P.-O.(2016). The correlation between regulatory conditions and antibiotic consumption within the WHO European Region . Health Policy. 120. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 882-889.

CONFERENCE ABSTRACT

(2019). Implementation of a pharmacotherapy service within General Practice: an evaluation of the educational resource supporting GP clinical pharmacists. Scottish Practice Pharmacy & Prescribing Advisers Association Annual Conference.

(2019). What matters to prostate cancer patients, carers and clinicians? Using consensus methods to identify Patient Reported Outcome Measures (PROMs) tools for use in clinical practice. Scottish Oncology Pharmacy Practice Group (SOPPG) 2019.

(2017). CHA2DS2-VASc Calculations in Patients with Atrial Fibrillation receiving oral anticoagulants in Scotland: an analysis of linked administrative data . International Journal of Population Data Science.

CONFERENCE POSTER

(2018). Using existing NHS datasets to determine outcomes of cancer medicines. 34th Conference on Pharmacoepidemiology & Therapeutic Risk Management.

(2018). Evaluating statin utilisation in clinical practice in Scotland. 34th Conference on Pharmacoepidemiology & Therapeutic Risk Management.

(2017). Applying a coherent framework to drug utilisation studies: the use of direct oral anticoagulants in patients with atrial fibrillation in Scotland. Annual Conference of the Royal Statistical Society.